Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J Schwarz
Observed names:
J. Schwarz,
Ji???? Schwarz,
Schwarz J
Observed institution:
Institute of Haematology and Blood Transfusion
OpenAlex ID:
A5111843172
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation
2016
·
A. Alvarez-Larran
, A. Pereira
, et al.
·
Haematologica
·
159
PDF
Real-time PCR quantification of major Wilms’ tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences
2012
·
K Kramarzova
, J Stuchly
, et al.
·
Leukemia
·
40
Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia.
2008
·
A Berkova
, L Pavlistova
, et al.
·
PubMed
·
16
Touch-Down Reverse Transcriptase-PCR Detection of IgVH Rearrangement and Sybr-Green-Based Real-Time RT-PCR Quantitation of Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia
2005
·
So??a Pekov??
, Jana Markov??
, et al.
·
Molecular Diagnosis
·
16
Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
2006
·
J Schwarz
, D Mikulenková
, et al.
·
PubMed
·
15
[Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
2011
·
J Schwarz
, M Penka
, et al.
·
PubMed
·
10
Advanced Rai Stage in Patients with Chronic Lymphocytic Leukaemia Correlates with Simultaneous Hypermethylation of Plural Tumour Suppressor Genes
2010
·
Kristina Forsterová
, H. Votavová
, et al.
·
Folia Biologica
·
6
PDF
Bone Marrow Histology Characteristics in MPL515 Mutated Thrombocythemia with Various Degrees of Myelofibrosis: A Cross Sectional Follow-up Study in Eight Cases
2018
·
Michiels JJ
, De Raeve H
, et al.
·
Journal of Hematology & Thromboembolic Diseases
·
5
The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis
2010
·
V Válková
, J Schwarz
, et al.
·
Hematological Oncology
·
5
The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group
2008
·
J Schwarz
, M Penka
, et al.
·
Leukemia
·
5
[Importance of prognostic factors in patients with chronic B-lymphocytic leukemia at the time of diagnosis].
2002
·
E Cmunt
, K Michalová
, et al.
·
PubMed
·
5
[The use of quantitative assessment of Wilms tumour gene 1 for monitoring of residual disease in acute myeloid leukemia patients].
2006
·
J Polák
, J Marková
, et al.
·
PubMed
·
4
[Summary of recommendations for the diagnosis and therapy of BCR/ABL-negative myeloproliferation of the Czech Working Group for Ph-negative myeloproliferative disease (CZEMP) of the Czech Hematologic Society CLS JEP ].
2012
·
M Penka
, J Schwarz
, et al.
·
PubMed
·
3
[Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006].
2007
·
M Penka
, J Schwarz
, et al.
·
PubMed
·
2
[Lymphocyte immunophenotyping and cytogenetics for more precise prognosis in patients with type B chronic lymphatic leukemia].
2003
·
E Cmunt
, K Michalová
, et al.
·
PubMed
·
2
[The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012].
2013
·
M Penka
, J Schwarz
, et al.
·
PubMed
·
1
New prognostic markers of chronic lymphocytic leukemia in theeveryday hematological practice. A multicenter analysis.
2009
·
Michael Doubek
, Eduard Cmunt
, et al.
·
Haematologica
·
1
Using Quantitative Assessment of the Wilms Tumor 1 Gene Expression in Residual Disease Monitoring in Patients with Acute Myeloid Leukemia
2006
·
J. Polák
, J Schwarz
, et al.
·
1
The impact of thrombophilia in the management of MPN
2016
·
J. Schwarz
·
Leukemia Research
Aktualizovaná doporučení pro diagnostiku a léčbu chronické lympfocytární leukémie (CLL) české CLL skupiny.
2016
·
Lukáš Smolej
, Martin Špaček
, et al.
[The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin].
2009
·
M Penka
, J Schwarz
, et al.
·
PubMed
[What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine].
2008
·
M Penka
, J Schwarz
, et al.
·
PubMed
Jak2 mutation and an additional thrombophilic state are majorprothrombotic risk factors in myeloproliferations withthrombocythemia - data from a registry of anagrelide-treatedpatients
2008
·
J Schwarz
, Miroslav Penka
, et al.
What can we currently learn from new prognostic markers ogchronic lymphocytic leukemia (CLL) in the everydayhaematological practise
2007
·
Michael Doubek
, Eduard Cmunt
, et al.
[Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
2006
·
M Penka
, M Doubek
, et al.
·
PubMed
Show more works
View as search
Works count:
26
Citation count:
296
H-index:
6
I10-index:
6
Year
Topic
Type
